MAK Capital
North America, New York, United States, New York
Description
MAK Capital outperform competitors over the long term by opportunistically investing in a fundamental
Investor Profile
MAK Capital has backed more than 4 startups, with 3 new investments in the last 12 months alone. The firm has led 2 rounds, about 50% of its total and boasts 0 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series Unknown, Series E, Series A rounds (top funding stages).
- Majority of deals are located in United States.
- Strong thematic focus on Biotechnology, Clinical Trials, Health Care.
- Led 1 rounds in the past year.
Stage Focus
- Series Unknown (50%)
- Series E (25%)
- Series A (25%)
Country Focus
- United States (100%)
Industry Focus
- Biotechnology
- Clinical Trials
- Health Care
- Life Science
- Medical
- Product Research
- Hardware
- Therapeutics
- Automotive
- Cleantech
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
